Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results

By G. M. Dam, G. Themelis, L. M. Crane, N. Harlaar, Rick G. Pleijhuis, W. Kelder, Athanasios Sarantopoulos, J. S. D. Jong, H. Arts, A. Zee and 3 more. Nature Medicine, 2011

1,540 citations recorded by the source corpus.

Subfields: Biomedical Engineering, Reproductive Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/989572b0915b7cfd54b060caf4f83b0482bc8e7b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biomedical Engineering

1. N. Bertrand
2. Xiaoyang Xu
3. N. Kamaly
4. Jun Wu
5. O. Farokhzad

Citations in the corpus

• Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. (2014, background): “For example, folate-targetedNPs co-encapsulating paclitaxel and yittrium-90 showed improved survival in a xenograft model of ovarian cancer [242] and folate-targeted fluorescent dyes were investigated in humans to improve surgical debulking of tumors using intraoperative tumor-specific visualization”